Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Feely

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|August 1, 1991
Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levelsK Wolff, A Hay, D Raistrick, et al.
Clinical Journal of Gastroenterology|February 20, 2021
HPV-16-associated lymphoepithelial-like carcinoma mimicking rectal tonsilPallavi Kopparthy, Joanna Chaffin, Michael M Feely, et al.
Chirality|January 1, 1997
Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patientsS D McAleer, A S Foondun, M Feely, et al.
European Journal of Pharmacology|August 22, 1986
Benzodiazepine cross-tolerance in mice extends to sodium valproateJ P Gent, M Bentley, M Feely, et al.
British Journal of Clinical Pharmacology|September 1, 1990
A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteersE Hardy, S Kumar, S Peaker, et al.
European Journal of Pharmacology|May 19, 1989
Lack of anticonvulsant tolerance with RU 32698 and Ro 17-1812M Feely, P Boyland, A Picardo, et al.
European Journal of Pharmacology|January 5, 1988
Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential?J C Garratt, J P Gent, M Feely, et al.
Anaesthesia|December 17, 2009
Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatmentN M Feely, D J Waghorn, T Dexter, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 11, 2002
Characterization of crude oils using fluorescence lifetime dataA G Ryder, T J Glynn, M Feely, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Use of a pharmacological indicator to monitor compliance with thyroxineN D Penn, S Peaker, A P Griffiths, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|August 1, 1991
Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levelsK Wolff, A Hay, D Raistrick, et al.
Clinical Journal of Gastroenterology|February 20, 2021
HPV-16-associated lymphoepithelial-like carcinoma mimicking rectal tonsilPallavi Kopparthy, Joanna Chaffin, Michael M Feely, et al.
Chirality|January 1, 1997
Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patientsS D McAleer, A S Foondun, M Feely, et al.
European Journal of Pharmacology|August 22, 1986
Benzodiazepine cross-tolerance in mice extends to sodium valproateJ P Gent, M Bentley, M Feely, et al.
British Journal of Clinical Pharmacology|September 1, 1990
A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteersE Hardy, S Kumar, S Peaker, et al.
European Journal of Pharmacology|May 19, 1989
Lack of anticonvulsant tolerance with RU 32698 and Ro 17-1812M Feely, P Boyland, A Picardo, et al.
European Journal of Pharmacology|January 5, 1988
Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential?J C Garratt, J P Gent, M Feely, et al.
Anaesthesia|December 17, 2009
Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatmentN M Feely, D J Waghorn, T Dexter, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 11, 2002
Characterization of crude oils using fluorescence lifetime dataA G Ryder, T J Glynn, M Feely, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Use of a pharmacological indicator to monitor compliance with thyroxineN D Penn, S Peaker, A P Griffiths, et al.
Pageof 10